SAS-B approvals continue to break records across 2021, with eight of the nine months showing an increase in prescriptions from the previous month.
September saw a huge 13,666 approvals being made to patients around the country, up 27% from August. That puts the total number of approvals in 2021 so far to 86,416, jumping 117% from the 39,823 approvals to September 2020.
The growth is on par with many experts’ predictions of Australia’s medical cannabis industry, with some describing it as an “important and quickly growing medical market” that is “poised to grow” with a CAGR of 30% between 2021 and 2028.
